An observational study in Neurodevelopmental Disorders, sponsored by Yeditepe University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 3 Years to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-13.
Sponsored by Yeditepe University · Observational
This study examines whether the relationship between reaction time and motor skills differs between children aged 3-6 with pervasive developmental disorders and typically developing peers. It aims to determine the direction and strength of this relationship in children with developmental disorders and compare it with that of typically developing children, thereby providing evidence on how cognitive processing speed and motor performance interact in early childhood under developmental disorder conditions.
This study is designed as a descriptive and comparative investigation aimed at examining differences in motor skills and reaction times between children aged 3-6 diagnosed with pervasive developmental disorders and their typically developing peers. The sample consists of 15 children with pervasive developmental disorders attending special education and rehabilitation centers and 15 typically developing children from the same age group.
No training or intervention program will be implemented; data will be collected through single-session, one-time assessments. To comprehensively evaluate motor skills, the Peabody Developmental Motor Scales-Second Edition (PDMS-2), widely regarded as a gold standard in child development assessment, will be used. In addition, participants' reaction times will be measured using the reaction test module of the Catch Pad application, a digital tool frequently utilized in scientific research.In this way, performance components including both general motor skills and response speed will be objectively measured, and differences between the two groups will be scientifically identified.
352 studies on the registry are indexed under Neurodevelopmental Disorders; 141 are open to participants now.
This study's planned enrollment of 30 is below the median of 200 across 133 observational studies indexed under Neurodevelopmental Disorders.
Browse Neurodevelopmental Disorders studies →Yeditepe University is the lead sponsor of 131 studies on the registry; 29 are open to participants now.
Counted across the registry records on this site, refreshed daily.
In this study, the sample will be selected using a purposive sampling method from children aged 3-6 years who meet the predefined inclusion and exclusion criteria.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Fifteen children aged between 3 and 6 years who have been diagnosed with pervasive developmental disorders.
Other: Peabody Developmental Motor Scales
Fifteen children aged between 3 and 6 years who have been typically developing peers
Other: Peabody Developmental Motor Scales
Motor skills will be assessed using the Peabody Developmental Motor Scales-Second Edition (PDMS-2), a standardized and validated tool measuring gross and fine motor performance. Subtests will be administered face-to-face in an age-appropriate manner and scored according to the manual.
Peabody Developmental Motor Scales
Reflexes, locomotor skills, object control, grasping, and visual-motor integration will be evaluated by this test
Time frame: One day
Simple Reaction Time Test
Reaction time will be evaluated by this test
Time frame: One day
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Apr 2026; primary completion for Jun 2026, 2 months later.
Of 67 non-industry observational studies under Neurodevelopmental Disorders, half reached primary completion within 59 months of starting (the median), counting those still running; a quarter within 32 and three quarters within 101. This study's planned 2 months is below that.
Counting every sponsor, half of 70 studies reached it within 59 months; a quarter within 32 and three quarters within 101.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Neurodevelopmental Disorders →